Narratives of the mystical among users of psychedelics
Drawing on interviews with 50 psychedelic users, this study finds that contemporary psychedelic “mystical” experiences conform to archetypal narratives characterised by transcendence of time and space, intense euphoria and a felt oneness with a larger whole. These archetypal patterns are shaped by culturally and politically specific storylines, notably environmental motifs of unity with plants and animals and a perceived duty to protect nature.
Abstract
We are now witnessing a radical revival in clinical research on the use of psychedelics (e.g. LSD and psilocybin), where ‘mystical’ experiences are at the centre. Drawing on in-depth interviews with 50 psychedelic drug users, we document how they draw on archetypical mystical narratives, comprising three key dimensions: (1) the transcendence of time and space; (2) deep euphoria; and (3) the perception of being at one with ‘a larger whole’. We suggest that the evolving new cultures around the use of psychedelics contain a variety of narratives, with clear roots in traditional mystical thinking. At the same time, these narratives reflect current cultural and political influences, including the narratives of oneness with plants and animals and our perceived need to protect nature. We conclude that the way people experience mystical occasions due to psychedelic use have archetypical patterns, but culturally specific storylines.
Research Summary of 'Narratives of the mystical among users of psychedelics'
Introduction
Mystical experiences have long been central to religious and philosophical accounts of human meaning, and recent clinical revival around psychedelics (for example LSD and psilocybin) has placed such experiences back at the centre of scientific interest. Classical dimensions of mysticism—ineffability, noetic quality, unity or loss of ego, and altered sense of time and space—are repeatedly reported in studies of psychedelic administration, yet most empirical work has been clinical and limited in examining how users outside therapeutic settings make sense of these events. There is also an ongoing debate about whether mystical experiences are universal in their core features or are culturally mediated by narrative resources available to the experiencer. Pedersen and colleagues set out to explore how people in Norway narratively construct and explain mystical experiences occasioned by psychedelics. Using a narrative identity framework, the study examines which cultural storylines participants draw on—particularly contemporary ecological and political themes—to render the ineffable intelligible and to account for reported personal changes following psychedelic use. The authors therefore aim to document both archetypal patterns of mystical experience and the culturally specific storylines that shape their interpretation.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Topic
- Author
- APA Citation
Pedersen, W., Copes, H., & Gashi, L. (2021). Narratives of the mystical among users of psychedelics. Acta Sociologica, 64(2), 230-246. https://doi.org/10.1177/0001699320980050
References (15)
Papers cited by this study that are also in Blossom
Carhart-Harris, R. L., Kaelen, M., Bolstridge, M. et al. · Psychological Medicine (2016)
Davis, A. K., Clifton, J. M., Weaver, E. G. et al. · Journal of Psychopharmacology (2020)
Forstmann, M., Sagioglou, C. · Journal of Psychopharmacology (2017)
Gashi, L., Sandberg, S., Pedersen, W. · International Journal of Drug Policy (2021)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Hendricks, P. S., Thorne, C. B., Clark, B. et al. · Journal of Psychopharmacology (2015)
´dric, C., Hysek, M., Schmid, Y. et al. · Social Cognitive and Affective Neuroscience (2013)
Johnson, M. W., Griffiths, R. R. · Neurotherapeutics (2017)
Johnstad, P. G. · Nordic Studies on Alcohol and Drugs (2018)
Show all 15 referencesShow fewer
Liechti, M. E. · Neuropsychopharmacology (2017)
Lyons, T., Carhart-Harris, R. L. · Journal of Psychopharmacology (2018)
Maclean, K. A., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2011)
Rucker, J., Iliff, J., Nutt, D. J. · Neuropharmacology (2017)
Webb, M., Copes, H., Hendricks, P. S. · International Journal of Drug Policy (2019)
Cited By (2)
Papers in Blossom that reference this study
Ponomarenko, P., Seragnoli, F., Calder, A. et al. · Journal of Psychopharmacology (2023)
Dollar, C. B. · Qualitative Criminology (2021)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.